Clinical trial

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

NCT00914758

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2009-03-01

PhaseN/A

Study timeline

Study start (unknown)2009-03-01Date precision: month

Registry last updated2009-06-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing Remitting Multiple Sclerosisunresolved

Interventions

Sponsors & collaborators

Washington Neuropsychology Research Grouplead sponsor

Genzyme, a Sanofi Companycollaborator

Mapped research locations

RochesterNew York, United States1 LexingtonKentucky, United States1 LebanonNew Hampshire, United States1 SpringfieldMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00914758 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.